Soyoung Lee
Soyoung Lee
Verified email at charite.de
Title
Cited by
Cited by
Year
Oncogene-induced senescence as an initial barrier in lymphoma development
M Braig, S Lee, C Loddenkemper, C Rudolph, AHFM Peters, ...
Nature 436 (7051), 660-665, 2005
12622005
A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy
CA Schmitt, JS Fridman, M Yang, S Lee, E Baranov, RM Hoffman, ...
Cell 109 (3), 335-346, 2002
11092002
Synthetic lethal metabolic targeting of cellular senescence in cancer therapy
JR Dörr, Y Yu, M Milanovic, G Beuster, C Zasada, JHM Däbritz, J Lisec, ...
Nature 501 (7467), 421-425, 2013
4032013
Senescence-associated reprogramming promotes cancer stemness
M Milanovic, DNY Fan, D Belenki, JHM Däbritz, Z Zhao, Y Yu, JR Dörr, ...
Nature 553 (7686), 96-100, 2018
3722018
The dynamic nature of senescence in cancer
S Lee, CA Schmitt
Nature cell biology 21 (1), 94-101, 2019
1892019
Tumor stroma-derived TGF-β limits myc-driven lymphomagenesis via Suv39h1-dependent senescence
M Reimann, S Lee, C Loddenkemper, JR Dörr, V Tabor, P Aichele, ...
Cancer cell 17 (3), 262-272, 2010
1622010
FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf
C Bouchard, S Lee, V Paulus-Hock, C Loddenkemper, M Eilers, ...
Genes & development 21 (21), 2775-2787, 2007
1432007
Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations
H Jing, J Kase, JR Dörr, M Milanovic, D Lenze, M Grau, G Beuster, S Ji, ...
Genes & development 25 (20), 2137-2146, 2011
982011
Chemotherapy response and resistance
S Lee, CA Schmitt
Current opinion in genetics & development 13 (1), 90-96, 2003
922003
NF-κB in cellular senescence and cancer treatment
H Jing, S Lee
Molecules and cells 37 (3), 189, 2014
862014
Targeting the senescence-overriding cooperative activity of structurally unrelated H3K9 demethylases in melanoma
Y Yu, K Schleich, B Yue, S Ji, P Lohneis, K Kemper, MR Silvis, N Qutob, ...
Cancer cell 33 (2), 322-336. e8, 2018
812018
Epigenetic regulation of histone H3 serine 10 phosphorylation status by HCF-1 proteins in C. elegans and mammalian cells
S Lee, V Horn, E Julien, Y Liu, J Wysocka, B Bowerman, MO Hengartner, ...
PloS one 2 (11), e1213, 2007
302007
Stabilization but not the transcriptional activity of herpes simplex virus VP16-induced complexes is evolutionarily conserved among HCF family members
S Lee, W Herr
Journal of virology 75 (24), 12402-12411, 2001
272001
The Myc/macrophage tango: oncogene-induced senescence, Myc style
S Lee, CA Schmitt, M Reimann
Seminars in cancer biology 21 (6), 377-384, 2011
142011
Recurrent chromosomal aberrations in INK4a/ARF defective primary lymphomas predict drug responses in vivo
A Helmrich, S Lee, P O'Brien, B Dörken, SW Lowe, E Schröck, CA Schmitt
Oncogene 24 (26), 4174-4182, 2005
112005
Extracorporeal photopheresis in graft-versus-host disease: ultraviolet radiation mediates T cell senescence in vivo
S Lee, B Dörken, CA Schmitt
Transplantation 78 (3), 484-485, 2004
112004
Non-cell-autonomous tumor suppression: oncogene-provoked apoptosis promotes tumor cell senescence via stromal crosstalk
M Reimann, CA Schmitt, S Lee
Journal of molecular medicine 89 (9), 869-875, 2011
92011
Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin lymphoma
J Du, M Neuenschwander, Y Yu, JHM Däbritz, NR Neuendorff, K Schleich, ...
Blood, The Journal of the American Society of Hematology 129 (1), 71-81, 2017
82017
Identification of cis-regulatory elements in the upstream regulatory region of human papillomavirus type 59
J Rho, S Lee, EM de Villiers, J Choe
Virus research 47 (2), 155-166, 1997
51997
Mouse models in cancer research
S Lee, CA Schmitt
Apoptosis and Cancer Therapy: From Cutting‐edge Science to Novel Therapeutic …, 2006
42006
The system can't perform the operation now. Try again later.
Articles 1–20